VEGFA and wet macular degeneration: Anti-VEGF is injected into patients with treatment of new onset wet AMD at day 0 to treat the CNV per standard of care and enable the AAVCAGsCD59 adequate time to enter the ganglion cells in the retina and start producing the transgene product.